Application effect of Roy adaptive nursing intervention in family members of children with congenital heart disease
LIU Zhengwei1 ZHOU Wanxing2▲
1.School of Nursing, Guangdong Pharmaceutical University, Guangdong Province, Guangzhou 510000, China;
2.Department of Cardiology, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Province, Guangzhou 510000, China
Abstract：Objective To investigate the effect of Roy adaptive nursing intervention on family intervention in children with congenital heart disease. Methods A total of 150 children with congenital heart disease who were treated in Department of Cardiac Surgery, Guangzhou Women and Children Medical Center from June to September 2017 were selected and randomly divided into study group and control group according to random number table, with 75 cases in each group. The relatives of children in the control group were given routine nursing intervention, including observation of the disease, basic nursing, and health guidance for the family members of the children. On the basis of the control group, the study group was given Roy adaptive nursing intervention during perioperative period. Both the two groups were intervened for 1 month. The satisfaction degree of nursing service was evaluated by the questionnaire of hospital nursing satisfaction. SDS and SAS were used to investigate the mental health status of the two groups. Results 85.45% of the children′s family members in the control group was satisfied with the nursing work, which was 98.18% in the study group, the difference was statistically significant (P < 0.05). The scores of SDS and SAS after intervention were significantly decreased compared with before intervention in the two groups (P < 0.05). The scores of SDS and SAS after intervention in the study group were lower than those in the control group, and the differences were statistically significant (P < 0.05). Conclusion Implementing Roy adaptive nursing model in children with cardiac surgery can not only create favorable conditions for surgery, but also improve the satisfaction of nursing services for children and their families, and make them feel safe during the medical treatment, reduce the anxiety for surgery of the relatives of children, thus improve the quality of care.
刘正伟1 周万兴2▲. 罗伊适应护理模式在先心病患儿家属干预中的应用效果[J]. 中国医药导报, 2018, 15(16): 177-180.
LIU Zhengwei1 ZHOU Wanxing2▲. Application effect of Roy adaptive nursing intervention in family members of children with congenital heart disease. 中国医药导报, 2018, 15(16): 177-180.
[1] Palumbo A，Chanan-Khan A，Weisel K，et al. CASTOR Investigators. Daratumumab，bortezomib and dexamethasone for multiple myeloma：CASTOR study [J]. N Engl J Med，2016，375（8）：754-766.
[2] Dimopoulos AM，Oriol A，Nahi H，et al. POLLUX Investigators. Daratumumab，lenalidomide and dexamethasone for multiple myeloma [J]. N Engl J Med，2016，375（14）：1319-1331.
[3] 樊永超.新形势下人文关怀护理在儿科门诊的实施[J].白求恩军医学院学报，2013，12（6）：3303-3306.
[4] Dimopoulos MA，Palumbo A，Corradini P，et al. Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS（MM-010）：a phase 3b study in refractory multiple myeloma [J]. Blood，2016，128（4）：497-503.
[5] 黄雪颖，白雅仙，刘亚景.运用罗伊适应模式对结肠癌造口术后患者的护理[J].临床合理用药杂志，2014，7（9）：166-167.
[6] Lin S，Pan J，Han L，et al. Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin [J]. Radiotherapy and Oncology，2014，110（3）：385-389.
[7] 孙振晓，刘化学，焦林瑛，等.医院焦虑已于量表的信度及效度研究[J].中华临床医师杂志：电子版，2017，11（2）：198-201.
[8] 顾晓红.人文关怀在儿科优质护理中的运用[J].当代护士：专科版，2013，10（8）：1025-1026.
[9] Clarke PN，Barone SH，Hanna D，et al. Roy′s adaptationmodel [J]. Nurs Sci Quart，2011，24（4）：337-344.
[10] 姜安丽.护理理论[M].北京：人民卫生出版社，2009：188-189.
[11] 唐敏.Roy适应模式在主动脉夹层瘤病人护理中的应用[J].护理研究，2015，29（7）：2664-2666.
[12] Moreau P，Masszi T，Grzasko N，et al. TOURMALINE-MM1 Study Group. Oral ixazomib，lenalidomide，and dexamethasone for multiple myeloma [J]. N Engl J Med，2016， 374（17）：1621-1634.
[13] 殷文珍，梁银爱，莫小燕，等.罗伊适应模式对髋臼骨折患者围术期心理及生活质量的影响[J].国际护理学杂志，2014，33（4）：923-925.
[14] Stewart AK，Rajkumar SV，Dimopoulos MA，et al. ASPIRE Investigators. Carfilzomib，lenalidomide，and dexamethasone for relapsed multiple myeloma [J]. N Engl J Med，2015，372（2）：142-152.
[15] Lonial S，Dimopoulos M，Palumbo A，et al. ELOQUENT-2 Investigators. Elotuzumab therapy for relapsed or refractory multiple myeloma [J]. N Engl J Med，2015，373（7）：621-631.
[16] Dimopoulos MA，Moreau P，Palumbo A，et al. ENDEAVOR Investigators. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma（ENDEAVOR）：a randomised，phase 3，open-label，multicentre study [J]. Lancet Oncol，2016，17（1）：27-38.
[17] 宋建如，熊英，赖婷.人文关怀理念应用于新生儿监护病房对患儿病情预后及护理质量的影响[J].国际护理学杂志，2014，11（6）：2055-2056.
[18] Hulin C，Belch A，Shustik C，et al. Updated outcomes and impact of age with lenalidomide and low-dose dexamethasone or melphalan，prednisone，and thalidomide in the randomized，phase III FIRST trial [J]. J Clin Oncol，2016，34（30）：3609-3617.
[19] Zweegman S，Van der Holt B，Mellqvist UH，et al. Melphalan，prednisone，and lenalidomide versus melphalan，prednisone，and thalidomide in untreated multiple myeloma [J]. Blood，2016，127（9）：1109-1116.
[20] Sharif F，Mahmoudi A，Shooshtari AA，et al. The Effect of Family-Centered Psycho-Education on Mental Health and Quality of Life of Families of Adolescents with Bipolar Mood Disorder：A Randomized Controlled Clinical Trial [J]. Int J Community Based Nur Midwifery，2016， 4（3）：229-238.
2018, Vol. 15 
京公网安备 11010502046598号